Overview of chemotherapy of cancer of the larynx.
D000470:Alkaloids / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002471:Cell Transformation, Neoplastic; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D006918:Hydroxyurea / Q000037:antagonists & inhibitors; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D008938:Mitosis / Q000187:drug effects; D009363:Neoplasm Proteins / Q000096:biosynthesis; D011743:Pyrimidines / Q000037:antagonists & inhibitors; D012334:RNA, Neoplasm / Q000096:biosynthesis
D000470:Alkaloids; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D005493:Folic Acid Antagonists; D009363:Neoplasm Proteins; D011743:Pyrimidines; D012334:RNA, Neoplasm; D006918:Hydroxyurea